Corey Brizzee, PhD

Director of Gene Editing at Demeetra

Speaker

Corey Brizzee oversees the microbial, mammalian, and plant gene editing groups at Demeetra. His responsibilities include further optimizing and developing our gene editing technologies. With his extensive knowledge in protein engineering and expression, Corey also leads the development of the next generation of Demeetra’s gene editing technologies. In addition to lab work, he assists our potential licensees with product applications and technical know-how.

Before coming to Demeetra, Corey received his PhD from the Department of Molecular and Cellular Biochemistry at the University of Kentucky. His graduate research featured a multi-directional approach in which biochemical analysis of enzymes and cellular biology techniques were utilized to understand metabolism in algae. He received his BA in Biology from the University of Rochester (NY), where he researched the role of transglutaminase2 (TG2) in hypoxia/ischemic stress conditions as well as the molecular mechanisms of tau degradation in Alzheimer disease.